LOS ANGELES, April 18, 2026 /PRNewswire/ -- Their discovery started with a group of blind dogs living at a vet school....
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase 4 study...
International Red Dot Jury recognizes Nanox.ARC X for design excellence that brings advanced 3D tomosynthesis imaging into a wider range of...
AGOURA HILLS, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We”), a clinical-stage...
Enhancing emergency triage imaging with Nanox.ARC to improve efficiency and lower radiation dose Collaboration expands clinical evidence base of Nanox.ARC...
SAN DIEGO and SUZHOU, China, April 14, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology...
Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems...
Board member and Interim CEO Mani Mohindru, PhD, named President and Chief Executive OfficerAppoints industry veterans Josh Muntner as Chief...
FRANKLIN LAKES, N.J., April 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology...
Subjects dosed in Phase 1 study evaluating safety and tolerability of a first-in-class multispecific antibodyWESTON, Mass., April 08, 2026 (GLOBE...
ADDISON, TX / ACCESS Newswire / April 7, 2026 / The Respiratory Care Interstate Compact (RCIC) is official with the...
CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present...
AIAW26 Runs April 6-10, Highlights the Critical Role of Well-Visits and AAP-Recommended ImmunizationsVENTNOR CITY, N.J., April 02, 2026 (GLOBE NEWSWIRE)...
New regional partnership strengthens Nanox’s presence and service support across outpatient imaging settings in Colorado, Wyoming and the western parts...
Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) --...
Med Tech segment delivered its sixth consecutive quarter of double-digit growth Strong adjusted EBITDA Third consecutive quarter the Company raised...
Distribution agreement to enhance channel partner expansion across five U.S. states The collaboration is expected to support adoption of advanced 3D...
SHELTON, CT / ACCESS Newswire / April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that a...
Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction...
The increase in median overall survival among women treated with IMNN-001 in the OVATION 2 trial rose from the previously...